| Ms Cynthia Dean Radclliff, RPH | |
|
808 W Main St, Battle Ground, WA 98604-9136 | |
| (360) 687-5136 | |
| (360) 687-5186 |
| Full Name | Ms Cynthia Dean Radclliff |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 808 W Main St, Battle Ground, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447572060 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH000015860 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Cynthia Dean Radclliff, RPH 808 W Main St, Battle Ground, WA 98604-9136 Ph: (360) 687-5136 | Ms Cynthia Dean Radclliff, RPH 808 W Main St, Battle Ground, WA 98604-9136 Ph: (360) 687-5136 |
News Archive
Reading specialists have often pitted phonics against holistic word recognition and whole language approaches in the war over how to teach children to read. However, a new study by researchers at New York University shows that the three reading processes do not conflict, but, rather, work together to determine speed.
Osmetech, plc today announced that the US Food and Drug Administration (FDA) has cleared the eSensor® Thrombophilia Risk Test (TRT), a multiplexed molecular diagnostic test for four genetic markers associated with thrombosis. The panel includes Factor V Leiden, Factor II Prothrombin, MTHFR 677 and MTHFR 1298 in a single test panel.
Assessment of patient outcomes allows physicians and researchers to measure the success or failure of diagnostics and treatments that patients receive. One set of measurement tools focuses on assessing adult pain and is included in a special issue of Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), providing physicians and researchers with a single resource of 250 patient outcomes measurements in rheumatology.
According to recently released figures, a high tech treatment for male infertility has become the most common therapy in Europe to help couples conceive.
Results from a randomized, open-label phase III trial suggest that a combination cream of halometasone and fusidic acid reduces symptoms of eczema to a similar degree to a betamethasone and neomycin sulphate cream, but is more effective at treating infected lesions.
› Verified 9 days ago
Mr. Mark Stuhrman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 Nw 12th Ave, Battle Ground, WA 98604 Phone: 360-666-5133 Fax: 360-666-5127 | |
Vitaliy Bejan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 W Main St, Battle Ground, WA 98604 Phone: 360-687-5133 | |
Ma Jerrylinn Ocampo Tanjutco, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 W Main St, Battle Ground, WA 98604 Phone: 360-687-5136 Fax: 360-687-5186 | |
Amy E Delia, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 W Main St, Battle Ground, WA 98604 Phone: 360-687-5186 | |
Dr. Dori Ann Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17513 Ne 110th Ave, Battle Ground, WA 98604 Phone: 503-949-2591 | |
Hollie Kristin Williams, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 Nw 12th Ave, Battle Ground, WA 98604 Phone: 360-666-5133 Fax: 360-666-5127 | |
Benjy D Scurlock, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 720 W Main St Ste 115, Battle Ground, WA 98604 Phone: 800-813-2000 |